Blood and Lymphatic Cancer: Targets and Therapy (Apr 2018)
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
Abstract
Anagnostou T, Litzow MR. Blood Lymphat Cancer.2018;8:1–9.On page 2, Table 1 was incorrectly presented. Read the original article